Regeneron Pharmaceuticals Correlations

REGN Stock

USD 681.58 11.65 1.68%

The current 90-days correlation between Regeneron Pharmaceuticals and Crispr Therapeutics AG is 0.37 (i.e., Weak diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Regeneron Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Regeneron Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Regeneron Pharmaceuticals Correlation With Market

Significant diversification

The correlation between Regeneron Pharmaceuticals and DJI is 0.06 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Regeneron Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Regeneron Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

To learn how to invest in Regeneron Stock, please use our How to Invest in Regeneron Pharmaceuticals guide.

Moving together with Regeneron Stock

0.8	EQ	Equillium	Pair Corr
0.9	ME	23Andme Holding	Pair Corr
0.82	VALN	Valneva SE ADR	Pair Corr
0.69	DNLI	Denali Therapeutics	Pair Corr
0.73	DNTH	Dianthus Therapeutics	Pair Corr
0.75	DOMH	Dominari Holdings	Pair Corr
0.82	DRRX	Durect	Pair Corr
0.82	DTIL	Precision BioSciences	Pair Corr
0.82	VIGL	Vigil Neuroscience	Pair Corr
0.87	VINC	Vincerx Pharma	Pair Corr
0.83	VKTX	Viking Therapeutics	Pair Corr
0.84	VRCA	Verrica Pharmaceuticals	Pair Corr
0.8	VRDN	Viridian Therapeutics Buyout Trend	Pair Corr
0.67	VRTX	Vertex Pharmaceuticals	Pair Corr

Moving against Regeneron Stock

0.91	VCEL	Vericel Corp Ord	Pair Corr
0.81	VCYT	Veracyte Potential Growth	Pair Corr
0.72	DRTS	Alpha Tau Medical	Pair Corr
0.62	DMAC	DiaMedica Therapeutics	Pair Corr
0.62	SABSW	SAB Biotherapeutics	Pair Corr
0.59	CDIOW	Cardio Diagnostics	Pair Corr
0.82	DVAX	Dynavax Technologies	Pair Corr
0.78	VRNA	Verona Pharma PLC	Pair Corr
0.76	DYAI	Dyadic International	Pair Corr
0.66	VSTM	Verastem	Pair Corr
0.63	SRZNW	Surrozen Warrant	Pair Corr
0.54	VYNE	Vyne Therapeutics	Pair Corr
0.53	VTRS	Viatris	Pair Corr
0.46	KTTAW	Pasithea Therapeutics	Pair Corr

Related Correlations Analysis

	CRSP	NVO	SRPT	NTLA	INCY	ALNY	UTHR	RARE	APLS	PTCT
CRSP		0.78	0.17	0.67	0.42	0.54	0.51	0.66	-0.15	-0.07	CRSP
NVO	0.78		0.27	0.83	-0.07	0.74	0.2	0.87	-0.31	-0.3	NVO
SRPT	0.17	0.27		0.25	-0.26	0.37	-0.16	0.37	0.29	0.2	SRPT
NTLA	0.67	0.83	0.25		-0.14	0.84	0.24	0.91	-0.41	-0.48	NTLA
INCY	0.42	-0.07	-0.26	-0.14		-0.15	0.78	-0.16	0.04	0.22	INCY
ALNY	0.54	0.74	0.37	0.84	-0.15		0.18	0.93	-0.58	-0.55	ALNY
UTHR	0.51	0.2	-0.16	0.24	0.78	0.18		0.14	-0.05	0.06	UTHR
RARE	0.66	0.87	0.37	0.91	-0.16	0.93	0.14		-0.49	-0.52	RARE
APLS	-0.15	-0.31	0.29	-0.41	0.04	-0.58	-0.05	-0.49		0.85	APLS
PTCT	-0.07	-0.3	0.2	-0.48	0.22	-0.55	0.06	-0.52	0.85		PTCT
	CRSP	NVO	SRPT	NTLA	INCY	ALNY	UTHR	RARE	APLS	PTCT

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

RARE	+ 0.93	ALNY
RARE	+ 0.91	NTLA
RARE	+ 0.87	NVO
PTCT	+ 0.85	APLS
ALNY	+ 0.84	NTLA
NTLA	+ 0.83	NVO

High negative correlations

APLS	- 0.58	ALNY
PTCT	- 0.55	ALNY
PTCT	- 0.52	RARE
APLS	- 0.49	RARE
PTCT	- 0.48	NTLA
APLS	- 0.41	NTLA

Risk-Adjusted Indicators

There is a big difference between Regeneron Stock performing well and Regeneron Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Regeneron Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
CRSP	2.61	(0.18)	0.00	1.08	0.00	0.00	5.70	(5.90)	17.42
NVO	1.63	(0.53)	0.00	(13.57)	0.00	0.00	2.57	(3.40)	20.65
SRPT	1.82	(0.07)	0.00	(0.19)	0.00	0.00	3.38	(4.19)	18.92
NTLA	3.57	(0.91)	0.00	(0.76)	0.00	0.00	5.18	(8.26)	25.94
INCY	1.64	0.16	0.07	0.39	2.19	(1.66)	3.27	(3.42)	20.37
ALNY	1.70	(0.18)	0.00	(0.79)	0.00	0.00	4.37	(3.88)	15.40
UTHR	1.28	0.04	0.02	0.12	1.97	(1.33)	2.89	(3.54)	9.81
RARE	1.70	(0.43)	0.00	(0.72)	0.00	0.00	2.81	(4.47)	11.58
APLS	2.57	0.20	0.05	0.29	3.79	(2.69)	4.63	(4.71)	27.73
PTCT	2.57	0.21	0.08	0.92	2.59	(3.14)	6.61	(4.33)	23.75

Regeneron Pharmaceuticals Corporate Management

Joseph JD	General VP	Profile
Patrice Gilooly	Senior Operations	Profile
Andrew Murphy	Executive Research	Profile
Christopher CPA	Head Finance	Profile
Bob McCowan	Senior Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC